This study summary is an excerpt from the book 2 Minute Medicine’s The Classics in Medicine: Summaries of the Landmark Trials
1. This case series of patients with novel coronavirus–infected pneumonia (NCIP) found that 32% were admitted to the intensive care unit (ICU) and 15% died.
2. A significant proportion of patients (29%) developed acute respiratory distress syndrome
Original Date of Publication: January 2020
Study Rundown: In this prospective case series, clinical features of NCIP patients in Wuhan, China were investigated during the beginning of the pandemic. The majority of patients were men without underlying chronic disease who had been exposed at the Huanan seafood market. The most common symptoms on initial presentation were fever, cough, myalgia, and fatigue. After admission, over half of patients developed lymphopenia and dyspnea. The present study was limited in that it evaluated a limited cohort of hospitalized patients. Thus, the findings cannot be extrapolated to the general population of COVID-19 patients. Additionally, only lower respiratory tract specimens were obtained to confirm diagnosis without information on viral load. In summary, COVID-19 infection may result in NCIP, severe respiratory distress, and subsequent ICU admission.
Click to read the study in The Lancet
EvidencePulse™by 2 Minute Medicine®
How does COVID-19 pneumonia patients in Wuhan, China apply to your patient?
Describe your patient and EvidencePulse weighs this trial against later evidence and current guidelines, with citations.
For a fuller review of the evidence, Deep research is a core feature of 2MM Max.
In-Depth [prospective case-series]: This prospective case series evaluated the clinical presentation and course of NCIP inpatients (n = 41). Almost three quarters of participants were male (73%) with a median age of 49. Only 32% of patients had underlying chronic disease, the most common being diabetes (20%). The most common presenting complaints were fever (98%) and cough (76%). Dyspnea occurred in 55% of patients at a median time of 8 days after initial symptoms. Acute respiratory distress syndrome occurred in 29% of patients with 15% of patients being admitted to the ICU and a 15% mortality rate. During initial evaluation, significantly increased prothrombin time (p = 0.012) and D-dimer levels (p = 0.0042) were seen in patients who were admitted to the ICU. Most patients were treated with antiviral therapy (93%), and all patients initially received empirical antibiotic treatment. Additionally, 22% of patients received systemic corticosteroids.
Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, Cheng Z. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The lancet. 2020 Feb 15;395(10223):497-506.
Trials since this one
What later trials found on the same question.
- 2021
Third dose of BNT162b2 COVID-19 vaccine effective at decreasing risk of hospitalization In The Classics
Compared to two doses of the BNT162b2 vaccine, a third booster dose was estimated to be 93% effective against admission to hospital due to COVID-19 infection.
- 2021
Inactivated whole-virion SARS-CoV-2 vaccine reduces rates of symptomatic COVID-19 infections In The Classics
Incidence of PCR-confirmed symptomatic COVID-19 cases was lower in the vaccine group compared with the placebo group.
5 more since 2020
2MM+ See every trial since COVID-19 pneumonia patients in Wuhan, China
2MM+ shows the full timeline of later trials on this question, with what each one found, and lets you save trials to reading lists for rounds, journal club and boards.
Citation: Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020 Feb 15;395(10223):497-506. doi: 10.1016/s0140-6736(20)30183-5. Epub 2020 Jan 24. PMID: 31986264; PMCID: PMC7159299.
© 2022 2 Minute Medicine, Inc. All rights reserved. No part of this article may be reproduced, distributed or transmitted in any form or by any means without the prior written permission of 2 Minute Medicine, Inc. To license this content, contact 2 Minute Medicine, Inc. This article is for informational and educational purposes only; it is not medical advice and does not replace the judgment of a qualified healthcare professional.
Image: © 2 Minute Medicine

